Call Today: 1-888-788-5353

Blog

kyc automation

You are convinced—automating your merchant Know Your Customer (KYC) due diligence process will greatly benefit your business. What now? How do you go from your current, manual processes to automation?  The first step is picking a vendor, and to do that, you need to clearly understand your requirements. Are you trying to improve compliance, or… read more

Nutraceuticals Claims Guide

When onboarding a nutraceutical merchant, how do you know which claims are compliant versus which claims cross the line? Obviously, a dietary supplement cannot be marketed with claims to miraculously cure COVID-19, but can it be marketed to relieve joint pain? Or reduce inflammation? What if the merchant’s website is claim-free, but its social media includes claims to help treat hypertension? Can a merchant… read more

In January 2019, the European Commission confirmed that CBD is considered a “novel food” in the EU.  A “novel food” is defined as “food that had not been consumed to a significant degree by humans in the EU before 15 May 1997.” Why is this important? Because “novel foods” must be authorized by the European… read more

merchant onboarding

By: Dan Frechtling, President, Verisk Financial | G2  Last week I was in Dubrovnik, Croatia, speaking on a panel at the Mastercard GRL Cybersecurity & Risk Summit. The topic was frictionless merchant onboarding, which employs digital information capture and automated tools in place of paper forms and manual review of traditional merchant applications. It is… read more

transaction laundering

With the continued growth of e-commerce, transaction laundering – a scheme in which an entity hides transactions for illicit goods and services through the use of a seemingly-unrelated merchant account – is on the rise. The payments industry has been aware of transaction laundering for years, and G2 (via our Transaction Laundering Detection Solution) has… read more

The US CBD market (which is projected to hit $16 billion by 2025) currently operates without significant federal oversight. Indeed, some describe the industry as the “wild west”—a regulatory-free zone that puts consumer safety at risk. On Friday, the FDA grasped the regulatory reins: the agency held a nearly 10-hour public hearing on cannabis-derived products…. read more

See how our solutions can help you.

Call Today:

1-888-788-5353

us